Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
Systemic Sclerosis (SSc) is a rheumatic disease characterized by fibrosis, microvascular damage and immune dysregulation. Two major subsets, limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSc) can be defined, according to the extent of skin involvement. Incr...
Saved in:
Main Authors: | Victoria Sundblad (Author), Ramiro A. Gomez (Author), Juan C. Stupirski (Author), Pablo F. Hockl (Author), Maria S. Pino (Author), Hugo Laborde (Author), Gabriel A. Rabinovich (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.
by: Alejandro F Benatar, et al.
Published: (2015) -
Galectin-1 Facilitates Macrophage Reprogramming and Resolution of Inflammation Through IFN-β
by: Hiba Yaseen, et al.
Published: (2020) -
Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
by: Ignacio M. Seropian, et al.
Published: (2018) -
Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019) -
Interrelation of galectin-3 and circulating proangiogenic endothelial cells in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014)